{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T14:49:33Z","timestamp":1771166973668,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"Horizon 2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["675671"],"award-info":[{"award-number":["675671"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"publisher","award":["URF\\R\\180019"],"award-info":[{"award-number":["URF\\R\\180019"]}],"id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today: Technologies"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ddtec.2020.11.007","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T02:58:18Z","timestamp":1616122698000},"page":"69-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Precise protein conjugation technology for the construction of homogenous glycovaccines"],"prefix":"10.1016","volume":"38","author":[{"given":"Annabel","family":"Kitowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Corzana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gon\u00e7alo J.L.","family":"Bernardes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"456","key":"10.1016\/j.ddtec.2020.11.007_bib0005","doi-asserted-by":"crossref","first-page":"eaat4615","DOI":"10.1126\/scitranslmed.aat4615","article-title":"Glycoconjugate vaccines: principles and mechanisms","volume":"10","author":"Rappuoli","year":"2018","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.ddtec.2020.11.007_bib0010","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/nm.2535","article-title":"A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design","volume":"17","author":"Avci","year":"2011","journal-title":"Nat Med"},{"issue":"24","key":"10.1016\/j.ddtec.2020.11.007_bib0015","doi-asserted-by":"crossref","first-page":"9015","DOI":"10.1039\/C8CS00495A","article-title":"Antimicrobial glycoconjugate vaccines: an overview of classic and modern approaches for protein modification","volume":"47","author":"Berti","year":"2018","journal-title":"Chem Soc Rev"},{"issue":"9","key":"10.1016\/j.ddtec.2020.11.007_bib0020","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1080\/14760584.2019.1657012","article-title":"Glycoconjugate vaccines: current approaches towards faster vaccine design","volume":"18","author":"Micoli","year":"2019","journal-title":"Expert Rev. Vaccines"},{"issue":"8","key":"10.1016\/j.ddtec.2020.11.007_bib0025","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1039\/c3sc50862e","article-title":"Synthetically defined glycoprotein vaccines: current status and future directions","volume":"4","author":"Adamo","year":"2013","journal-title":"Chem Sci"},{"issue":"6","key":"10.1016\/j.ddtec.2020.11.007_bib0030","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3390\/molecules23061451","article-title":"Protein carriers for glycoconjugate vaccines: history, selection criteria, characterization and new trends","volume":"23","author":"Micoli","year":"2018","journal-title":"Molecules"},{"issue":"5683","key":"10.1016\/j.ddtec.2020.11.007_bib0035","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1126\/science.1095209","article-title":"A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b","volume":"305","author":"Verez-Bencomo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ddtec.2020.11.007_bib0040","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT0407822?view=record."},{"key":"10.1016\/j.ddtec.2020.11.007_bib0045","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04602975?cond=Shigella&draw=2&rank=28."},{"issue":"4","key":"10.1016\/j.ddtec.2020.11.007_bib0050","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.4049\/jimmunol.0803141","article-title":"A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection","volume":"182","author":"Phalipon","year":"2009","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.ddtec.2020.11.007_bib0055","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.4049\/jimmunol.176.3.1686","article-title":"Characterization of functional oligosaccharide mimics of the Shigella flexneri serotype 2a O-antigen: implications for the development of a chemically defined glycoconjugate vaccine","volume":"176","author":"Phalipon","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.ddtec.2020.11.007_bib0060","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02853617?term=PNAG&draw=2&rank=1."},{"issue":"7","key":"10.1016\/j.ddtec.2020.11.007_bib0065","doi-asserted-by":"crossref","first-page":"e1007160","DOI":"10.1371\/journal.ppat.1007160","article-title":"Antibody to Poly-N-acetyl glucosamine provides protection against intracellular pathogens: mechanism of action and validation in horse foals challenged with Rhodococcus equi","volume":"14","author":"Cywes-Bentley","year":"2018","journal-title":"PLoS Pathog"},{"issue":"9","key":"10.1016\/j.ddtec.2020.11.007_bib0070","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1021\/cr400355w","article-title":"Cellular incorporation of unnatural amino acids and bioorthogonal labeling of proteins","volume":"114","author":"Lang","year":"2014","journal-title":"Chem Rev"},{"issue":"7","key":"10.1016\/j.ddtec.2020.11.007_bib0075","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1021\/bc800294a","article-title":"Nonnatural amino acids for site-selective protein conjugation","volume":"20","author":"Graaf","year":"2009","journal-title":"Bioconjugate Chem"},{"key":"10.1016\/j.ddtec.2020.11.007_bib0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature24031","article-title":"Expanding and reprogramming the genetic code","volume":"550","author":"Chin","year":"2017","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ddtec.2020.11.007_bib0085","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1021\/acs.bioconjchem.5b00101","article-title":"Site-specific glycoconjugation of protein via bioorthogonal tetrazine cycloaddition with a genetically encoded trans-cyclooctene or bicyclononyne","volume":"26","author":"Machida","year":"2015","journal-title":"Bioconjugate Chem"},{"issue":"16","key":"10.1016\/j.ddtec.2020.11.007_bib0090","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1039\/C7CS00184C","article-title":"Inverse electron demand Diels\u2013Alder reactions in chemical biology","volume":"46","author":"Oliveira","year":"2017","journal-title":"Chem Soc Rev"},{"issue":"31","key":"10.1016\/j.ddtec.2020.11.007_bib0095","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1002\/ejoc.201800602","article-title":"Synthesis of azido-glycans for chemical glycomodification of proteins","author":"Wawryszyn","year":"2018","journal-title":"Eur. J. Org. Chem. 2018"},{"issue":"7","key":"10.1016\/j.ddtec.2020.11.007_bib0100","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/bit.23103","article-title":"Microscale to manufacturing scale-up of cell-free cytokine production \u2013 a new approach for shortening protein production development timelines","volume":"108","author":"Zawada","year":"2011","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.ddtec.2020.11.007_bib0105","unstructured":"https:\/\/vaxcyte.com\/pipeline\/."},{"issue":"6","key":"10.1016\/j.ddtec.2020.11.007_bib0110","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/cbic.201300785","article-title":"Defined conjugation of glycans to the lysines of CRM197 guided by their reactivity mapping","volume":"15","author":"Crotti","year":"2014","journal-title":"Chembiochem"},{"issue":"45","key":"10.1016\/j.ddtec.2020.11.007_bib0115","doi-asserted-by":"crossref","first-page":"13198","DOI":"10.1002\/anie.201506112","article-title":"Sugar-protein connectivity impacts on the immunogenicity of site-selective Salmonella O-antigen glycoconjugate vaccines","volume":"54","author":"Stefanetti","year":"2015","journal-title":"Angew Chem Int Ed"},{"issue":"11","key":"10.1016\/j.ddtec.2020.11.007_bib0120","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1021\/jacs.7b12874","article-title":"Chemo- and regioselective lysine modification on native proteins","volume":"140","author":"Matos","year":"2018","journal-title":"J Am Chem Soc"},{"issue":"7","key":"10.1016\/j.ddtec.2020.11.007_bib0125","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1021\/acs.biochem.8b01223","article-title":"Site-selective lysine reactions guided by protein\u2013peptide interaction","volume":"58","author":"Zhang","year":"2019","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.ddtec.2020.11.007_bib0130","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1039\/c4mb00018h","article-title":"Understanding and applying tyrosine biochemical diversity","volume":"10","author":"Jones","year":"2014","journal-title":"Mol. Biosyst."},{"issue":"10","key":"10.1016\/j.ddtec.2020.11.007_bib0135","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1039\/c3sc51694f","article-title":"Synthesis of a well-defined glycoconjugate vaccine by a tyrosine-selective conjugation strategy","volume":"4","author":"Hu","year":"2013","journal-title":"Chem Sci"},{"issue":"12","key":"10.1016\/j.ddtec.2020.11.007_bib0140","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1021\/bc500438h","article-title":"Tyrosine-directed conjugation of large glycans to proteins via copper-free click chemistry","volume":"25","author":"Nilo","year":"2014","journal-title":"Bioconjugate Chem"},{"issue":"7","key":"10.1016\/j.ddtec.2020.11.007_bib0145","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1021\/acschembio.5b00247","article-title":"Anti-group B Streptococcus glycan-conjugate vaccines using pilus protein GBS80 as carrier and antigen: comparing lysine and tyrosine-directed conjugation","volume":"10","author":"Nilo","year":"2015","journal-title":"ACS Chem Biol"},{"issue":"8","key":"10.1016\/j.ddtec.2020.11.007_bib0150","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1021\/acs.bioconjchem.5b00365","article-title":"Exploring the effect of conjugation site and chemistry on the immunogenicity of an anti-group B Streptococcus glycoconjugate vaccine based on GBS67 pilus protein and type v polysaccharide","volume":"26","author":"Nilo","year":"2015","journal-title":"Bioconjugate Chem"},{"issue":"49","key":"10.1016\/j.ddtec.2020.11.007_bib0155","doi-asserted-by":"crossref","first-page":"15942","DOI":"10.1021\/ja0439017","article-title":"A three-component mannich-type reaction for selective tyrosine bioconjugation","volume":"126","author":"Joshi","year":"2004","journal-title":"J Am Chem Soc"},{"issue":"5","key":"10.1016\/j.ddtec.2020.11.007_bib0160","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1021\/ja909062q","article-title":"Tyrosine bioconjugation through aqueous ene-type reactions: a click-like reaction for tyrosine","volume":"132","author":"Ban","year":"2010","journal-title":"J Am Chem Soc"},{"issue":"11","key":"10.1016\/j.ddtec.2020.11.007_bib0165","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1021\/acschembio.5b00440","article-title":"Tyrosine-specific chemical modification with in situ hemin-activated luminol derivatives","volume":"10","author":"Sato","year":"2015","journal-title":"ACS Chem Biol"},{"issue":"5","key":"10.1016\/j.ddtec.2020.11.007_bib0170","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/asia.200800427","article-title":"Chemical modification of proteins at cysteine: opportunities in chemistry and biology","volume":"4","author":"Chalker","year":"2009","journal-title":"Chem. Asian J."},{"issue":"40","key":"10.1016\/j.ddtec.2020.11.007_bib0175","doi-asserted-by":"crossref","first-page":"10585","DOI":"10.1002\/anie.201405702","article-title":"Cysteine-selective reactions for antibody conjugation","volume":"53","author":"Cal","year":"2014","journal-title":"Angew Chem Int Ed"},{"issue":"10","key":"10.1016\/j.ddtec.2020.11.007_bib0180","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1021\/bc200148v","article-title":"Tunable degradation of maleimide\u2013thiol adducts in reducing environments","volume":"22","author":"Baldwin","year":"2011","journal-title":"Bioconjugate Chem"},{"issue":"2","key":"10.1016\/j.ddtec.2020.11.007_bib0185","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.2108","article-title":"Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates","volume":"30","author":"Shen","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ddtec.2020.11.007_bib0190","doi-asserted-by":"crossref","first-page":"14963","DOI":"10.1002\/anie.201708847","article-title":"Oxetane grafts site-selectively installed on native disulfides enhance protein stability and activity in vivo","volume":"56","author":"Mart\u00ednez-S\u00e1ez","year":"2017","journal-title":"Angew Chem Int Ed"},{"issue":"5","key":"10.1016\/j.ddtec.2020.11.007_bib0195","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1039\/C6SC00005C","article-title":"Water-soluble allyl sulfones for dual site-specific labelling of proteins and cyclic peptides","volume":"7","author":"Wang","year":"2016","journal-title":"Chem Sci"},{"issue":"3","key":"10.1016\/j.ddtec.2020.11.007_bib0200","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1039\/C8SC04645J","article-title":"A general approach for the site-selective modification of native proteins, enabling the generation of stable and functional antibody\u2013drug conjugates","volume":"10","author":"Walsh","year":"2019","journal-title":"Chem Sci"},{"key":"10.1016\/j.ddtec.2020.11.007_bib0205","doi-asserted-by":"crossref","first-page":"13128","DOI":"10.1038\/ncomms13128","article-title":"Stoichiometric and irreversible cysteine-selective protein modification using carbonylacrylic reagents","volume":"7","author":"Bernardim","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.ddtec.2020.11.007_bib0210","unstructured":"Articles reviewed in this section were also quoted and reviewed in other sections."},{"issue":"1","key":"10.1016\/j.ddtec.2020.11.007_bib0215","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1073\/pnas.1819612116","article-title":"On the mechanisms of conjugate vaccines","volume":"116","author":"Rappuoli","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.ddtec.2020.11.007_bib0220","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1039\/C4SC01361A","article-title":"Deciphering the structure\u2013immunogenicity relationship of anti-Candida glycoconjugate vaccines","volume":"5","author":"Adamo","year":"2014","journal-title":"Chem Sci"},{"key":"10.1016\/j.ddtec.2020.11.007_bib0225","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3389\/fchem.2019.00726","article-title":"Site-specific conjugation for fully controlled glycoconjugate vaccine preparation","volume":"7","author":"Pillot","year":"2019","journal-title":"Front Chem"}],"container-title":["Drug Discovery Today: Technologies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1740674920300299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1740674920300299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T16:22:21Z","timestamp":1761668541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1740674920300299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":45,"alternative-id":["S1740674920300299"],"URL":"https:\/\/doi.org\/10.1016\/j.ddtec.2020.11.007","relation":{},"ISSN":["1740-6749"],"issn-type":[{"value":"1740-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precise protein conjugation technology for the construction of homogenous glycovaccines","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today: Technologies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ddtec.2020.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}